HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Pre-IPO Medbanks Network Technology - Conservative About the Outlook

Pre-IPO ClouDr Group - The Logical Business Model Can Support Future Growth

JD Health (6618.HK) 2021 Results - The Logic and the Outlook

Ping An Good Doctor (1833.HK) - It Is the Time to Look at Some Concerns

Pre-IPO Dingdang Health Technology - The Future Looks Challenging

JD Health (6618.HK) - Opportunities Coexist with Challenges

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Equity Bottom-Up

Ping An Healthcare and Technology / Equity Bottom-Up

Ping An Healthcare and Technology (1833 HK)

<p>On August 24, 2021, <a href="https://www.smartkarma.com/entities/ping-an-healthcare-and-technology-company-limited" target="_blank" data-smartkarma-citation="entities:27008:1" rel="noopener">Ping An Healthcare and Technology Company Limited (1833 HK) </a>(PAGD) released its 2021 interim results. The revenue was RMB3.82 billion, up 39% YoY. Gross profit was RMB1.025 billion, up 24.8% YoY. Net loss was RMB879.3 million, up 312% YoY. After the financial report was released, PAGD’s share price fell about 13.7% for three consecutive days from August 25, reflecting the attitude of the market. This insight mainly analyzed PAGD in terms of its performance in 2021/1H, the business and the underlying logic, the concerns and the outlook of the Company.</p>

On August 24, 2021, Ping An Healthcare and Technology Company Limited (1833 HK) (PAGD) released its 2021 interim results. The revenue was RMB3.82 billion, up 39% YoY. Gross profit was RMB1.025 billion, up 24.8% YoY. Net loss was RMB879.3 million, up 312% YoY. After the financial report was released, PAGD’s share price fell about 13.7% for three consecutive days from August 25, reflecting the attitude of the market. This insight mainly analyzed PAGD in terms of its performance in 2021/1H, the business and the underlying logic, the concerns and the outlook of the Company.

Ping An Good Doctor (1833.HK) - A Vicious Cycle?